Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

ProMIS Neurosciences Inc PMN

ProMIS Neurosciences Inc. is a clinical-stage biotechnology company. It is focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA). Its proprietary target discovery engine applies a thermodynamic, computational discovery platform-ProMIS and Collective Coordinates-to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins. Using this approach, the Company is developing novel antibody therapeutics for AD, ALS and MSA. Its product candidates are PMN310, PMN267, and PMN442. The PMN310 is a monoclonal antibody designed to treat AD by selectively targeting toxic, misfolded oligomers of amyloid-beta. PMN267 product candidate targeting ALS. PMN442 is a drug candidate being developed for MSA designed to selectively target and protect against pathogenic a-syn species.


NDAQ:PMN - Post by User

Bullboard Posts
Comment by jjwilsonon Jan 20, 2019 12:41pm
79 Views
Post# 29257037

RE:RE:RE:Clinicals trials?

RE:RE:RE:Clinicals trials?"Someone sure is sensitive and butt hurt lol. I don’t like sitting on dead money period. I would rather sell at a loss so that I can invest that money somewhere else instead of just sitting and doing nothing and losing value. I am not a day trader. I asked an honest question about the clinical trials, which should say that I do follow the company. I clearly didn’t invest at .20 or .21. All this assuming you’re doing  is really making an a*s out of you. If this is how you treat everyone you misunderstand, you mustn’t have a lot of friends. I’m not going to stoop to your level. Thanks for nothing JJ. Forgot how much of an entitled prik you are. Go cry someplace else."

I'm reacting to your claim that you "really believe" in PMN and nothing else.  I understand your desire to move your money around and to find the most promising opportunities but don't try to tell us you believe in the company when you obviously don't.  In your last post you said, "it's unfortunate that the stock didn't go up more" as you sell your shares!  Do you not see a contradication here?  It's guys like you who sell their shares that take the momentum away from the company.

Look, I understand how the market works and your investment strategy from last year is perfectly valid, you made some money for yourself so congratulations on that.

The problem is that your stategy is at odds with mine, indeed it is at odds with any longterm investor and detrimental to the company and it irks me that you would come here and ask for advice from longtime, involved and knowledgeable PMN investors on how to invest against their interests while claiming to "truly believe in PMN."  

Buy, sell, short - I can't stop you but I'm not going to help you and especially don't like being told that you believe in the company when your actions clearly indicate otherwise.  You see there's many of us here that really do believe in the company.  Aside from potential financial gain there are many who hope and pray for a viable treatment to AD and other catastrophic diseases and we want the company to be succuessful.  

Constant selling of shares for small amounts of profit has been identified as one of the issues that has been holding the company back therefore helping you with your short-term investing runs against my financial interests and against my desire to see the company successfully develope a treatment or technology and discoveries that lead to a treatment.

Regarding your other points;  

 - I have lots of friends
 - I did not misunderstand you
 - I am not crying, butthurt or entitled


Bullboard Posts